Second-line chemotherapy efficacy in patients with previously treated advanced thymic carcinoma: A retrospective analysis of 192 patients from NEJ023 Study.

Shunichiro Iwasawa,Ryo Ko,Takehito Shukuya,Satoshi Watanabe,Yoko Tsukita,Hironori Ashinuma,Taku Nakagawa,Ryo Ito,Kazutsugu Uematsu,Mika Nakao,Yoshiaki Mori,Kyoichi Kaira,Atsuto Mouri,Takao Miyabayashi,Hiroyuki Sakashita,Yoko Matsumoto,Tomoyuki Tanigawa,Satoshi Morita,Kazuhisa Takahashi

Second-line chemotherapy efficacy in patients with previously treated advanced thymic carcinoma: A retrospective analysis of 192 patients from NEJ023 Study.

2016

Shunichiro Iwasawa
Ryo Ko
Takehito Shukuya
Satoshi Watanabe
Yoko Tsukita
Hironori Ashinuma
Taku Nakagawa
Ryo Ito
Kazutsugu Uematsu
Mika Nakao
Yoshiaki Mori
Kyoichi Kaira
Atsuto Mouri
Takao Miyabayashi
Hiroyuki Sakashita
Yoko Matsumoto
Tomoyuki Tanigawa
Satoshi Morita
Kazuhisa Takahashi

8569Background: Thymic carcinoma is a rare neoplasm. Minimal information exists regarding second-line chemotherapy efficacy in patients with previously treated advanced thymic carcinoma. Methods: W...

Keywords:

Thymic carcinoma
General surgery
Pathology
Chemotherapy
Medicine
Neoplasm
previously treated
in patient
Oncology
Internal medicine
retrospective analysis
second line chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations